Gene transfer approaches to the healing of bone and cartilage

Molecular Therapy

Volumn 6, Issue 2, 2002, Pages 141-147

  Lieberman, Jay R ^a   Ghivizzani, Steven C ^b   Evans, Christopher H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FIBROBLAST GROWTH FACTOR; GENE PRODUCT; GROWTH FACTOR; LIM MINERALIZATION PROTEIN 1; LIPOSOME; OSTEOGENIC PROTEIN 1; PARATHYROID HORMONE[1-34]; PLASMID DNA; PROTEIN BCL 2; SMAD PROTEIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICULAR CARTILAGE; BONE MARROW CELL; BONE REMODELING; GENE EXPRESSION; GENE TARGETING; GENE TECHNOLOGY; GENE THERAPY; GENE TRANSFER; GENETIC ENGINEERING; GENETIC TRANSDUCTION; HEALING; MEDICAL TECHNOLOGY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; OSSIFICATION; OSTEOLYSIS; REVIEW; SPINE FUSION; TISSUE REPAIR; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE;

EID: 0036665006     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2000.0663     Document Type: Review

References (63)

1. Evans, C. H., and Robbins, P. D. (1995). Possible orthopaedic applications of gene therapy. J. Bone Joint Surg. Am. 77: 1103-1114.
2. Evans, C. H., et al. (2000). Using gene therapy to protect and restore cartilage. Clin. Orthop. 379 (Suppl.): S214-s219.
3. Oakes, D. A., and Deberman, J. R. (2000). Osteoinductive applications of regional gene therapy: ex vivo gene transfer. Clin. Orthop. 379 (Suppl.): S101-s112.
4. Scaduto, A. A., and Lieberman, J. R. (1999). Gene therapy for osteoinduction. Orthop. Clin. North Am. 30: 625-633.
5. Lieberman, J. R., et al. (1999). The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J. Bone Joint Surg. Am. 81: 905-917.
6. Colterjohn, N. R., and Bednar, D. A. (1997). Procurement of bone graft from the iliac crest. An operative approach with decreased morbidity. J. Bone Joint Surg. Am. 79: 756-759.
7. Arrington, E. D., et al. (1996). Complications of iliac crest bone graft harvesting. Clin. Orthop. 329: 300-309.
8. Gerhart, T. N., et al. (1993). Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin. Orthop. 293: 317-326.
9. Cook, S. D., et al. (1994). Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin. Orthop. 301: 302-312.
10. Cook, S. D., et al. (1995). Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J. Bone Joint Surg. Am. 77: 734-750.
11. Sandhu, H. S., et al. (1995). Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model. Spine 20: 2669-2682.
12. Boden, S. D., et al. (1998). Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage. J. Spinal Disord. 11: 95-101.
13. Friedlaender, G. E., et al. (2001). Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J. Bone Joint Surg. Am. 83-A (Suppl. 1 (Pt. 2)): S151-S158.
14. Boden, S. D., et al. (2000). The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 25: 376-381.
15. Crystal, R. G. (1995). Transfer of genes to humans: early lessons and obstacles to success. Science 270: 404-410.
16. Anderson, W. F. (1998). Human gene therapy. Nature 392 (Suppl.): 25-30.
17. Wilson, J. M. (1996). Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334: 1185-1187.
18. Baltzer, A. W., et al. (2000). Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther. 7: 734-739.
19. Musgrave, D. S., et al. (1999). Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 24: 541-547.
20. Okubo, Y., et al. (2000). Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression. Biochem. Biophys. Res. Commun. 267: 382-387.
21. Fang, J., et al. (1996). Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc. Natl. Acad. Sci. USA 93: 5753-5758.
22. Bonadio, J., et al. (1999). Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat. Med. 5: 753-759.
23. Viggeswarapu, M., et al. (2001). Adenoviral delivery of LIM mineralization protein-1 induces new-bone formation in vitro and in vivo. J. Bone Joint Surg. Am. 83-A: 364-376.
24. Bruder, S. P., Jaiswal, N., and Haynesworth, S. E. (1997). Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J. Cell Biochem. 64: 278-294.
25. Bruder, S. P., et al. (1998). Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J. Orthop. Res. 16: 155-162.
26. Bruder, S. P., et al. (1998). The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J. Bone Joint Surg. Am. 80: 985-996.
27. Krebsbach, P. H., et al. (2000). Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum. Gene Ther. 11: 1201-1210.
28. Lee, J. Y., et al. (2001). Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J. Bone Joint Surg. Am. 83-A: 1032-1039.
29. Zuk, P. A., et al. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7: 211-228.
30. Dragoo, J., et al. (2001). Bone induction by genetically manipulated stem cells derived from fat. J. Bone Min. Res. 16 (suppl. 1): 5500.
31. Deutsche Banc, A. B. (2001). Estimates and Company Information.
32. Boden, S. D., et al. (1998). Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1). Spine 23: 2486-2492.
33. Wang, J., et al. (2002). Intertransverse process fusion in Lewis rats using bone marrow cells infected with a BMP-2 containing adenovirus. Trans. Orthop. Res. Soc. 25: 327.
34. Athanasiou, K. A., et al. (2001). Basic science of articular cartilage repair. Clin. Sports Med. 20: 223-247.
35. O'Connor, W. J., et al. (2000). The use of growth factors in cartilage repair. Orthop. Clin. North Am. 31: 399-410.
36. Uusitalo, H., et al. (2001). Accelerated up-regulation of L-Sox5, Sox6, and Sox9 by BMP-2 gene transfer during murine fracture healing. J. Bone Miner. Res. 16: 1837-1845.
37. Fujii, M., et al. (1999). Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol. Biol. Cell 10: 3801-3813.
38. Feng, L., et al. (1998). Evidence of a direct role for Bcl-2 in the regulation of articular chondrocyte apoptosis under the conditions of serum withdrawal and retinoic acid treatment. J. Cell. Biochem. 71: 302-309.
39. Evans, C. H., et al. (1996). Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum. Gene Ther. 7: 1261-1280.
40. Mi, Z., et al. (2000). Adenovirus-mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints. Arthritis Rheum. 43: 2563-2570.
41. Gelse, K., et al. (2001). Fibroblast-mediated delivery of growth factor complementary DNA into mouse joints induces chondrogenesis but avoids the disadvantages of direct viral gene transfer. Arthritis Rheum. 44: 1943-1953.
42. Tomita, T., et al. (1997). In vivo direct gene transfer into articular cartilage by intraarticular injection mediated by HVJ (Sendai virus) and liposomes. Arthritis Rheum. 40: 901-906.
43. Arai, Y., et al. (2000). Gene delivery to human chondrocytes by an adeno associated virus vector. J. Rheumatol. 27: 979-982.
44. Brittberg, M., et al. (2001). Autologous chondrocytes used for articular cartilage repair: an update. Clin. Orthop. 391 (Suppl.): S337-S348.
45. Madry, H., and Trippel, S. B. (2000). Efficient lipid-mediated gene transfer to articular chondrocytes. Gene Ther. 7: 286-291.
46. Shuler, F. D., et al. (2000). Increased matrix synthesis following adenoviral transfer of a transforming growth factor β1 gene into articular chondrocytes. J. Orthop. Res. 18: 585-592.
47. Smith, P., et al. (2000). Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1. Arthritis Rheum. 43: 1156-1164.
48. Nixon, A. J., et al. (2000). Insulinlike growth factor-I gene therapy applications for cartilage repair. Clin. Orthop. 379 (suppl.): S201-S213.
49. Kang, R., et al. (1997). Ex vivo gene transfer to chondrocytes in full-thickness articular cartilage defects: a feasibility study. Osteoarth. Cartilage 5: 139-143.
50. Baragi, V. M., et al. (1997). Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo. Osteoarth. Cartilage 5: 275-282.
51. Ostrander, R. V., et al. (2001). Donor cell fate in tissue engineering for articular cartilage repair. Clin. Orthop. 389: 228-237.
52. Madry, H., Zurakowski, D., and Trippel, S. B. (2001). Overexpression of human insulin-like growth factor-I promotes new tissue formation in an ex vivo model of articular chondrocyte transplantation. Gene Ther. 8: 1443-1449.
53. Kaps, C., et al. (2002). Bone morphogenetic proteins promote cartilage differentiation and protect engineered artificial cartilage from fibroblast invasion and destruction. Arthritis Rheum. 46: 149-162.
54. Johnstone, B., et al. (1998). In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 238: 265-272.
55. Wakitani, S., et al. (1994). Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J. Bone Joint Surg. Am. 76: 579-592.
56. Yoo, J. U., et al. (2000). Chondrogenitor cells and gene therapy. Clin. Orthop. 379 (Suppl.): S164-S170.
57. Mason, J. M., et al. (1998). Expression of human bone morphogenic protein 7 in primary rabbit periosteal cells: potential utility in gene therapy for osteochondral repair. Gene Ther. 5: 1098-1104.
58. Goomer, R. S., et al. (2000). Nonviral in vivo gene therapy for tissue engineering of articular cartilage and tendon repair. Clin. Orthop. 379 (Suppl.): S189-S200.
59. Doherty, P. J., et al. (1998). Resurfacing of articular cartilage explants with genetically-modified human chondrocytes in vitro. Osteoarth. Cartilage 6: 153-159.
60. Palmer, G., et al. (2002). Direct gene transfer to osteochondral defects. Trans. Orthop. Res. Soc. 27: 292.
61. Goto, H., et al. (1999). Transfer of lacZ marker gene to the meniscus. J. Bone Joint Surg. Am. 81: 918-925.
62. Goto, H., et al. (2000). Gene therapy for meniscal injury: enhanced synthesis of proteoglycan and collagen by meniscal cells transduced with a TGFβ(1)gene. Osteoarth. Cartilage 8: 266-271.
63. Nishida, K., et al. (1999). Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirus-mediated transfer of the human transforming growth factor β 1 encoding gene. Spine 24: 2419-2425.